The approval of Novartis AG’s (SWX: NOVN) gene therapy drug that costs $2.1 million set a new standard in terms of cost for gene therapy medications and made headlines across the globe.
However, the drug achieved another milestone in that it is the first time that a drug can treat a complicated illness using a single dosage at such a high cost.
While the drug’s cost is quite prohibitive, it treats a disease that most other drugs simply manage and treat over a long period of time. This is first in the industry, which is probably why the drug costs millions, but it is my hope that over time other drugs may enter the market at a friendlier price point.
There is a lot of research being done on the CRISPR gene editing technology, which could drastically revolutionize the medical industry, but the technology is yet to pass clinical trials.
However, while most people wait for the CRISPR technology to become available on a large scale and at a cheaper price, many infants affected by spinal muscular atrophy may have no option but to use the world’s most expensive treatment.
Novartis products treat and prevent a range of diseases and conditions from hypertension and cancer to cataracts and migraines. I don't think that this product can help in future gene therapy. For example, I used recently for treating my anxiety and depression a medicine called bulk kratom. That's a medicine that keeps your mind in shape. Relieves stress and anxiety. Various research studies have found that Kratom is useful in inspiring a positive state of mind and causing users to have a more optimistic attitude about life in general. After one week of using kratom I started thinking more optimistic and more energetic, I started see all beautiful things around me. Hope it was useful information for you :)
You need to be a member in order to leave a comment
Sign up for a new account in our community. It's easy!
Already have an account? Sign in here.